Table 1.
Comparison of ZFNs, TALENs, and CRISPR/Cas9 Nuclease Systems for Genome Editing
Genome Editing Tool | ZFNs | TALENs | CRISPR/Cas9 |
---|---|---|---|
Features | ZF-FokI nuclease protein fusion | TALE-FokI nuclease protein fusion | Cas9 nuclease and sgRNA |
Target site identification | protein-DNA interaction, capable of targeting virtually any site | protein-DNA interaction, capable of targeting virtually any site | RNA-DNA interaction, site selection restricted by the NGG motif, which occurs statistically every 8 nt in a random DNA sequence |
Genome altering | DSBs directed by the FokI domain, repaired through NHEJ or HDR | DSBs directed by the FokI domain, repaired through NHEJ or HDR | DSBs directed by Cas9, repaired through NHEJ or HDR |
Design | + | ++ | +++ |
custom design based on the target sequence, labor intensive and time-consuming | custom design based on the target sequence, labor intensive, less time-consuming than ZFN | very simple design by altering the crRNA sequence of the sgRNA | |
Efficiency | ++ | ++ | +++ |
Biallelic targeting | ++ | ++ | +++ |
Off-target effects | ++ | +++ | + |
specific | more specific than ZFN | low compared with ZFN and TALEN as a result of allowed mismatches by the Cas9 nuclease between sgRNA and the DNA target sequence | |
Multiplexing | + | + | +++ |
rarely used | rarely used | yes, capable of targeting multiple sites simultaneously | |
Size and delivery | +++ | ++ | + |
the ZFN monomer is significantly smaller than Cas9 | TALEN monomers are situated in the middle of Cas9 and ZFN nucleases in terms of size | massive Cas9 protein encoded by a 4.2-kb sequence |